Motor Neuron Involvement in a Patient with Long-term Corticosteroid Administration

An asthmatic patient with corticosteroid treatment for 45 years presented with slowly progressive limb muscle atrophy. His muscle symptoms were involved in four limbs and tongue, and deep tendon reflexes were exaggerated. Biopsied muscle pathology indicated the presence of neurogenic muscular atroph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2003, Vol.42(9), pp.862-866
Hauptverfasser: MTSUI, Takao, UMAKI, Yoshifumi, NAGASAWA, Masakazu, AKAIKE, Masashi, OHTSUKA, Satoshi, ODOMI, Masaaki, AKI, Kenji, MATSUMOTO, Toshio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 866
container_issue 9
container_start_page 862
container_title Internal Medicine
container_volume 42
creator MTSUI, Takao
UMAKI, Yoshifumi
NAGASAWA, Masakazu
AKAIKE, Masashi
OHTSUKA, Satoshi
ODOMI, Masaaki
AKI, Kenji
MATSUMOTO, Toshio
description An asthmatic patient with corticosteroid treatment for 45 years presented with slowly progressive limb muscle atrophy. His muscle symptoms were involved in four limbs and tongue, and deep tendon reflexes were exaggerated. Biopsied muscle pathology indicated the presence of neurogenic muscular atrophy in combination with corticosteroid myopathy. Furthermore, 8-hydroxy-deoxyguanosine (8-OH-dG) was prominently increased in mitochondrial and nuclear DNA. An aerobic exercise test demonstrated remarkable serum lactate elevation, which was attenuated by the administration of coenzyme Q10- These findings are consistent with the assumption that long-term corticosteroid administration potentially induces not only myopathy but also motor neuron involvement as in mitochondrial diseases. (Internal Medicine 42: 862-866, 2003)
doi_str_mv 10.2169/internalmedicine.42.862
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_2169_internalmedicine_42_862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14518677</sourcerecordid><originalsourceid>FETCH-LOGICAL-c551t-6e60b966bf19d448d222dfdb170da4d2c341739533d6b3befe7e87b4dae2a5543</originalsourceid><addsrcrecordid>eNplkFtLwzAYhoMobk7_gvbGy87m0Ca5HMPDYOoQvS5pk24ZbTKSbOK_N2VjA735wkeeN3l5ALiD2RjBgj9oE5Qzou2U1LU2akzQmBXoDAwhJjylCOfnYJhxyFIUxwBceb_OMswoR5dgAEkOWUHpEHy82mBd8qa2zppkZna23alOmZBok4hkIYLul28dVsncmmUa_-2SqXVB19bHxWqZTGSnjfbBRdqaa3DRiNarm8M5Al9Pj5_Tl3T-_jybTuZpnecwpIUqsooXRdVALglhEiEkG1lBmklBJKoxgRTzHGNZVLhSjaKK0YpIoZDIc4JHgO7frZ313qmm3DjdCfdTwqzsLZV_LZUEldFSTN7uk5ttFe9OuYOWCNwfAOFr0TZOmFr7E5cjxmjGIrfYc2sfxFIdAdHradW_ApBz1Jfg-xG7HNF6JVypDP4F7E-UxA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Motor Neuron Involvement in a Patient with Long-term Corticosteroid Administration</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>MTSUI, Takao ; UMAKI, Yoshifumi ; NAGASAWA, Masakazu ; AKAIKE, Masashi ; OHTSUKA, Satoshi ; ODOMI, Masaaki ; AKI, Kenji ; MATSUMOTO, Toshio</creator><creatorcontrib>MTSUI, Takao ; UMAKI, Yoshifumi ; NAGASAWA, Masakazu ; AKAIKE, Masashi ; OHTSUKA, Satoshi ; ODOMI, Masaaki ; AKI, Kenji ; MATSUMOTO, Toshio</creatorcontrib><description>An asthmatic patient with corticosteroid treatment for 45 years presented with slowly progressive limb muscle atrophy. His muscle symptoms were involved in four limbs and tongue, and deep tendon reflexes were exaggerated. Biopsied muscle pathology indicated the presence of neurogenic muscular atrophy in combination with corticosteroid myopathy. Furthermore, 8-hydroxy-deoxyguanosine (8-OH-dG) was prominently increased in mitochondrial and nuclear DNA. An aerobic exercise test demonstrated remarkable serum lactate elevation, which was attenuated by the administration of coenzyme Q10- These findings are consistent with the assumption that long-term corticosteroid administration potentially induces not only myopathy but also motor neuron involvement as in mitochondrial diseases. (Internal Medicine 42: 862-866, 2003)</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.42.862</identifier><identifier>PMID: 14518677</identifier><language>eng</language><publisher>Tokyo: The Japanese Society of Internal Medicine</publisher><subject>Aged ; asthma ; Asthma - drug therapy ; Betamethasone - adverse effects ; Biological and medical sciences ; Biopsy ; corticosteroid myopathy ; denervation ; Drug toxicity and drugs side effects treatment ; Electromyography ; Glucocorticoids - adverse effects ; Humans ; Male ; Medical sciences ; mitochondria ; Mitochondria, Muscle - drug effects ; Mitochondrial Myopathies - chemically induced ; Mitochondrial Myopathies - diagnosis ; Mitochondrial Myopathies - metabolism ; Motor Neuron Disease - chemically induced ; Motor Neuron Disease - diagnosis ; Motor Neuron Disease - metabolism ; Muscle, Skeletal - innervation ; Muscle, Skeletal - pathology ; Muscular Atrophy - chemically induced ; Muscular Atrophy - pathology ; Muscular Atrophy - physiopathology ; neurogenic muscular atrophy ; Oxidative Stress - physiology ; Pharmacology. Drug treatments ; Toxicity: nervous system and muscle</subject><ispartof>Internal Medicine, 2003, Vol.42(9), pp.862-866</ispartof><rights>The Japanese Society of Internal Medicine</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c551t-6e60b966bf19d448d222dfdb170da4d2c341739533d6b3befe7e87b4dae2a5543</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,1884,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15288708$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14518677$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MTSUI, Takao</creatorcontrib><creatorcontrib>UMAKI, Yoshifumi</creatorcontrib><creatorcontrib>NAGASAWA, Masakazu</creatorcontrib><creatorcontrib>AKAIKE, Masashi</creatorcontrib><creatorcontrib>OHTSUKA, Satoshi</creatorcontrib><creatorcontrib>ODOMI, Masaaki</creatorcontrib><creatorcontrib>AKI, Kenji</creatorcontrib><creatorcontrib>MATSUMOTO, Toshio</creatorcontrib><title>Motor Neuron Involvement in a Patient with Long-term Corticosteroid Administration</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>An asthmatic patient with corticosteroid treatment for 45 years presented with slowly progressive limb muscle atrophy. His muscle symptoms were involved in four limbs and tongue, and deep tendon reflexes were exaggerated. Biopsied muscle pathology indicated the presence of neurogenic muscular atrophy in combination with corticosteroid myopathy. Furthermore, 8-hydroxy-deoxyguanosine (8-OH-dG) was prominently increased in mitochondrial and nuclear DNA. An aerobic exercise test demonstrated remarkable serum lactate elevation, which was attenuated by the administration of coenzyme Q10- These findings are consistent with the assumption that long-term corticosteroid administration potentially induces not only myopathy but also motor neuron involvement as in mitochondrial diseases. (Internal Medicine 42: 862-866, 2003)</description><subject>Aged</subject><subject>asthma</subject><subject>Asthma - drug therapy</subject><subject>Betamethasone - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>corticosteroid myopathy</subject><subject>denervation</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Electromyography</subject><subject>Glucocorticoids - adverse effects</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>mitochondria</subject><subject>Mitochondria, Muscle - drug effects</subject><subject>Mitochondrial Myopathies - chemically induced</subject><subject>Mitochondrial Myopathies - diagnosis</subject><subject>Mitochondrial Myopathies - metabolism</subject><subject>Motor Neuron Disease - chemically induced</subject><subject>Motor Neuron Disease - diagnosis</subject><subject>Motor Neuron Disease - metabolism</subject><subject>Muscle, Skeletal - innervation</subject><subject>Muscle, Skeletal - pathology</subject><subject>Muscular Atrophy - chemically induced</subject><subject>Muscular Atrophy - pathology</subject><subject>Muscular Atrophy - physiopathology</subject><subject>neurogenic muscular atrophy</subject><subject>Oxidative Stress - physiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Toxicity: nervous system and muscle</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkFtLwzAYhoMobk7_gvbGy87m0Ca5HMPDYOoQvS5pk24ZbTKSbOK_N2VjA735wkeeN3l5ALiD2RjBgj9oE5Qzou2U1LU2akzQmBXoDAwhJjylCOfnYJhxyFIUxwBceb_OMswoR5dgAEkOWUHpEHy82mBd8qa2zppkZna23alOmZBok4hkIYLul28dVsncmmUa_-2SqXVB19bHxWqZTGSnjfbBRdqaa3DRiNarm8M5Al9Pj5_Tl3T-_jybTuZpnecwpIUqsooXRdVALglhEiEkG1lBmklBJKoxgRTzHGNZVLhSjaKK0YpIoZDIc4JHgO7frZ313qmm3DjdCfdTwqzsLZV_LZUEldFSTN7uk5ttFe9OuYOWCNwfAOFr0TZOmFr7E5cjxmjGIrfYc2sfxFIdAdHradW_ApBz1Jfg-xG7HNF6JVypDP4F7E-UxA</recordid><startdate>20030901</startdate><enddate>20030901</enddate><creator>MTSUI, Takao</creator><creator>UMAKI, Yoshifumi</creator><creator>NAGASAWA, Masakazu</creator><creator>AKAIKE, Masashi</creator><creator>OHTSUKA, Satoshi</creator><creator>ODOMI, Masaaki</creator><creator>AKI, Kenji</creator><creator>MATSUMOTO, Toshio</creator><general>The Japanese Society of Internal Medicine</general><general>Japanese Society of Internal Medicine</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20030901</creationdate><title>Motor Neuron Involvement in a Patient with Long-term Corticosteroid Administration</title><author>MTSUI, Takao ; UMAKI, Yoshifumi ; NAGASAWA, Masakazu ; AKAIKE, Masashi ; OHTSUKA, Satoshi ; ODOMI, Masaaki ; AKI, Kenji ; MATSUMOTO, Toshio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c551t-6e60b966bf19d448d222dfdb170da4d2c341739533d6b3befe7e87b4dae2a5543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>asthma</topic><topic>Asthma - drug therapy</topic><topic>Betamethasone - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>corticosteroid myopathy</topic><topic>denervation</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Electromyography</topic><topic>Glucocorticoids - adverse effects</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>mitochondria</topic><topic>Mitochondria, Muscle - drug effects</topic><topic>Mitochondrial Myopathies - chemically induced</topic><topic>Mitochondrial Myopathies - diagnosis</topic><topic>Mitochondrial Myopathies - metabolism</topic><topic>Motor Neuron Disease - chemically induced</topic><topic>Motor Neuron Disease - diagnosis</topic><topic>Motor Neuron Disease - metabolism</topic><topic>Muscle, Skeletal - innervation</topic><topic>Muscle, Skeletal - pathology</topic><topic>Muscular Atrophy - chemically induced</topic><topic>Muscular Atrophy - pathology</topic><topic>Muscular Atrophy - physiopathology</topic><topic>neurogenic muscular atrophy</topic><topic>Oxidative Stress - physiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Toxicity: nervous system and muscle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MTSUI, Takao</creatorcontrib><creatorcontrib>UMAKI, Yoshifumi</creatorcontrib><creatorcontrib>NAGASAWA, Masakazu</creatorcontrib><creatorcontrib>AKAIKE, Masashi</creatorcontrib><creatorcontrib>OHTSUKA, Satoshi</creatorcontrib><creatorcontrib>ODOMI, Masaaki</creatorcontrib><creatorcontrib>AKI, Kenji</creatorcontrib><creatorcontrib>MATSUMOTO, Toshio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MTSUI, Takao</au><au>UMAKI, Yoshifumi</au><au>NAGASAWA, Masakazu</au><au>AKAIKE, Masashi</au><au>OHTSUKA, Satoshi</au><au>ODOMI, Masaaki</au><au>AKI, Kenji</au><au>MATSUMOTO, Toshio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Motor Neuron Involvement in a Patient with Long-term Corticosteroid Administration</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2003-09-01</date><risdate>2003</risdate><volume>42</volume><issue>9</issue><spage>862</spage><epage>866</epage><pages>862-866</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>An asthmatic patient with corticosteroid treatment for 45 years presented with slowly progressive limb muscle atrophy. His muscle symptoms were involved in four limbs and tongue, and deep tendon reflexes were exaggerated. Biopsied muscle pathology indicated the presence of neurogenic muscular atrophy in combination with corticosteroid myopathy. Furthermore, 8-hydroxy-deoxyguanosine (8-OH-dG) was prominently increased in mitochondrial and nuclear DNA. An aerobic exercise test demonstrated remarkable serum lactate elevation, which was attenuated by the administration of coenzyme Q10- These findings are consistent with the assumption that long-term corticosteroid administration potentially induces not only myopathy but also motor neuron involvement as in mitochondrial diseases. (Internal Medicine 42: 862-866, 2003)</abstract><cop>Tokyo</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>14518677</pmid><doi>10.2169/internalmedicine.42.862</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2003, Vol.42(9), pp.862-866
issn 0918-2918
1349-7235
language eng
recordid cdi_crossref_primary_10_2169_internalmedicine_42_862
source J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Aged
asthma
Asthma - drug therapy
Betamethasone - adverse effects
Biological and medical sciences
Biopsy
corticosteroid myopathy
denervation
Drug toxicity and drugs side effects treatment
Electromyography
Glucocorticoids - adverse effects
Humans
Male
Medical sciences
mitochondria
Mitochondria, Muscle - drug effects
Mitochondrial Myopathies - chemically induced
Mitochondrial Myopathies - diagnosis
Mitochondrial Myopathies - metabolism
Motor Neuron Disease - chemically induced
Motor Neuron Disease - diagnosis
Motor Neuron Disease - metabolism
Muscle, Skeletal - innervation
Muscle, Skeletal - pathology
Muscular Atrophy - chemically induced
Muscular Atrophy - pathology
Muscular Atrophy - physiopathology
neurogenic muscular atrophy
Oxidative Stress - physiology
Pharmacology. Drug treatments
Toxicity: nervous system and muscle
title Motor Neuron Involvement in a Patient with Long-term Corticosteroid Administration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T17%3A40%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Motor%20Neuron%20Involvement%20in%20a%20Patient%20with%20Long-term%20Corticosteroid%20Administration&rft.jtitle=Internal%20Medicine&rft.au=MTSUI,%20Takao&rft.date=2003-09-01&rft.volume=42&rft.issue=9&rft.spage=862&rft.epage=866&rft.pages=862-866&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.42.862&rft_dat=%3Cpubmed_cross%3E14518677%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/14518677&rfr_iscdi=true